Parkinsonism as neurological presentation of late-onset cerebrotendinous xanthomatosis

Parkinsonism and Related Disorders

Volumn 18, Issue 1, 2012, Pages 99-101

  Mignarri, Andrea ^a   Falcini, Mario ^b   Vella, Alessandra ^a   Giorgio, Antonio ^a   Gallus, Gian Nicola ^a   Del Puppo, Marina ^c   Vattimo, Angelo ^a   Federico, Antonio ^a   Dotti, Maria Teresa ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Azienda Ospedaliera di Prato   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHENODEOXYCHOLIC ACID; CHOLESTANOL; DOPAMINE TRANSPORTER;

AGED; ANAMNESIS; BRADYKINESIA; BRAIN ATROPHY; BRAIN DAMAGE; CASE REPORT; CAUDATE NUCLEUS; CEREBELLUM ATROPHY; CEREBROTENDINOUS XANTHOMATOSIS; CLINICAL FEATURE; CYP27A1 GENE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAND TREMOR; HUMAN; LETTER; MARKER GENE; MINI MENTAL STATE EXAMINATION; MOTOR EXAMINATION SCORE; NEUROLOGIC EXAMINATION; PARKINSONISM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; SCORING SYSTEM; SIGNAL DETECTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPEECH DISORDER; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; WHITE MATTER;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PARKINSONIAN DISORDERS; TIME FACTORS; XANTHOMATOSIS, CEREBROTENDINOUS;

EID: 84655161937     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.06.004     Document Type: Letter

References (5)

1. Federico A., Dotti M.T. Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 2003, 18:633-638.
2. De Stefano N., Dotti M.T., Mortilla M., Federico A. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 2001, 124:121-131.
3. Su C.S., Chang W.N., Huang S.H., Lui C.C., Pan T.L., Lu C.H., et al. Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings. Mov Disord 2010, 25:452-458.
4. Huang C.C., Chu N.S., Yen T.C., Wai Y.Y., Lu C.S. Dopamine transporter binding in Wilson's disease. Can J Neurol Sci 2003, 30(2):163-167.
5. Kim J.M., Kim J.S., Jeong S.H., Kim Y.K., Kim S.E., Kim S.H., et al. Dopaminergic neuronal integrity in parkinsonism associated with liver cirrhosis. Neurotoxicology 2010, 31:351-355.